Effective Immediately: OncoSec Names Former Advaxis Exec as New CEO Post author:Sam Post published:November 7, 2017 Post category:BioPharma OncoSec Medical today announced the appointment of Daniel J. O’Connor as CEO of the Company. Source: BioSpace You Might Also Like The Next Biotech 'Unicorn,' Ginkgo Bioworks, Just Nabbed Another $275M December 13, 2017 Mirati Therapeutics Reports Second Quarter 2017 Financial Results August 3, 2017 SoCal's Evolus Files for $75M IPO January 8, 2018